25 XP   0   0   10

Tus Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Tus Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Tus Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tus Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tus Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Tus Pharmaceutical Group Co Ltd.

Quick analysis of Tus Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Tus Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
94.9%

What is your share worth?

Current worth
¥3.04
Expected worth in 1 year
¥3.15
How sure are you?
76.9%

+ What do you gain per year?

Total Gains per Share
¥0.12
Return On Investment
2.0%

For what price can you sell your share?

Current Price per Share
¥6.29
Expected price per share
¥4.8 - ¥8.63
How sure are you?
50%

1. Valuation of Tus Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥6.29

Intrinsic Value Per Share

¥-0.68 - ¥-0.81

Total Value Per Share

¥2.36 - ¥2.23

2. Growth of Tus Pharmaceutical Group Co Ltd (5 min.)




Is Tus Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$100.6m$96.5m$2m2.1%

How much money is Tus Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$872.2k$626.9k$245.3k28.1%
Net Profit Margin5.2%0.8%--

How much money comes from the company's main activities?

3. Financial Health of Tus Pharmaceutical Group Co Ltd (5 min.)




What can you expect buying and holding a share of Tus Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Tus Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Tus Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Tus Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Tus Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Tus Pharmaceutical Group Co Ltd is ¥6.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tus Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tus Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.04. Based on the TTM, the Book Value Change Per Share is ¥0.03 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tus Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.2%0.000.1%0.000.0%0.000.1%0.000.0%
Usd Book Value Change Per Share0.010.2%0.000.1%0.000.0%0.000.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.2%0.000.1%0.000.0%0.000.1%0.010.1%
Usd Price Per Share1.24-1.22-1.21-1.35-1.70-
Price to Earnings Ratio28.51-2,160.79--34.65-475.96-417.82-
Price-to-Total Gains Ratio104.67-1,291.59--271.72-346.54-516.84-
Price to Book Ratio2.95-2.96-3.01-3.56-8.32-
Price-to-Total Gains Ratio104.67-1,291.59--271.72-346.54-516.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.869278
Number of shares1150
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (1150 shares)4.965.15
Gains per Year (1150 shares)19.8520.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13171012011
26343023932
38515035953
411687037974
514859049995
6171021105118116
7191191306138137
8221361507158158
9251541708178179
10281711909197200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%28.06.05.071.8%57.06.024.065.5%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%28.011.00.071.8%54.033.00.062.1%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.00.02.094.9%64.00.023.073.6%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%18.02.00.090.0%30.09.00.076.9%62.025.00.071.3%

Fundamentals of Tus Pharmaceutical Group Co Ltd

About Tus Pharmaceutical Group Co Ltd

Tus-Pharmaceutical Group Co., Ltd. manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China. The company offers Guhan health essences, Danzao oral liquids, Danhuang granules, and Yangxin Dingpalan granules. It also provides tonic health care, cardiovascular and cerebrovascular products, children's nutrition, cold products, heat-clearing, and detoxification products, etc. The company was formerly known as Tus-Guhan Group Corp.,Ltd. Tus-Pharmaceutical Group Co., Ltd. was founded in 1956 and is headquartered in Hengyang, China.

Fundamental data was last updated by Penke on 2024-04-13 17:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Tus Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tus Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Tus Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 14.5% means that ¥0.14 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tus Pharmaceutical Group Co Ltd:

  • The MRQ is 14.5%. The company is making a huge profit. +2
  • The TTM is 5.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ14.5%TTM5.2%+9.3%
TTM5.2%YOY0.8%+4.4%
TTM5.2%5Y7.8%-2.6%
5Y7.8%10Y4.9%+2.9%
1.1.2. Return on Assets

Shows how efficient Tus Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tus Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.6% Return on Assets means that Tus Pharmaceutical Group Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tus Pharmaceutical Group Co Ltd:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.6%TTM0.5%+1.1%
TTM0.5%YOY0.4%+0.1%
TTM0.5%5Y0.8%-0.2%
5Y0.8%10Y0.7%+0.1%
1.1.3. Return on Equity

Shows how efficient Tus Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tus Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.6% Return on Equity means Tus Pharmaceutical Group Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tus Pharmaceutical Group Co Ltd:

  • The MRQ is 2.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.6%TTM0.9%+1.7%
TTM0.9%YOY0.7%+0.2%
TTM0.9%5Y1.1%-0.2%
5Y1.1%10Y1.5%-0.4%

1.2. Operating Efficiency of Tus Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tus Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Tus Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tus Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tus Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.8%-1.8%
TTM1.8%YOY-0.4%+2.3%
TTM1.8%5Y6.9%-5.1%
5Y6.9%10Y0.5%+6.3%
1.2.2. Operating Ratio

Measures how efficient Tus Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.40 means that the operating costs are ¥1.40 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Tus Pharmaceutical Group Co Ltd:

  • The MRQ is 1.402. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.430. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.402TTM1.430-0.028
TTM1.430YOY2.398-0.968
TTM1.4305Y1.581-0.151
5Y1.58110Y1.138+0.443

1.3. Liquidity of Tus Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tus Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.17 means the company has ¥2.17 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Tus Pharmaceutical Group Co Ltd:

  • The MRQ is 2.169. The company is able to pay all its short-term debts. +1
  • The TTM is 2.168. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.169TTM2.168+0.001
TTM2.168YOY2.521-0.353
TTM2.1685Y2.995-0.827
5Y2.99510Y1.826+1.170
1.3.2. Quick Ratio

Measures if Tus Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tus Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.09 means the company can pay off ¥0.09 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tus Pharmaceutical Group Co Ltd:

  • The MRQ is 0.087. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.634. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.087TTM0.634-0.547
TTM0.634YOY0.962-0.328
TTM0.6345Y0.804-0.170
5Y0.80410Y0.692+0.112

1.4. Solvency of Tus Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tus Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tus Pharmaceutical Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.37 means that Tus Pharmaceutical Group Co Ltd assets are financed with 36.7% credit (debt) and the remaining percentage (100% - 36.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tus Pharmaceutical Group Co Ltd:

  • The MRQ is 0.367. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.373. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.367TTM0.373-0.006
TTM0.373YOY0.335+0.038
TTM0.3735Y0.302+0.071
5Y0.30210Y0.401-0.098
1.4.2. Debt to Equity Ratio

Measures if Tus Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tus Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 58.4% means that company has ¥0.58 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tus Pharmaceutical Group Co Ltd:

  • The MRQ is 0.584. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.599. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.584TTM0.599-0.014
TTM0.599YOY0.518+0.081
TTM0.5995Y0.443+0.155
5Y0.44310Y0.812-0.369

2. Market Valuation of Tus Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Tus Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Tus Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 28.51 means the investor is paying ¥28.51 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tus Pharmaceutical Group Co Ltd:

  • The EOD is 20.013. Based on the earnings, the company is fair priced.
  • The MRQ is 28.508. Based on the earnings, the company is overpriced. -1
  • The TTM is 2,160.789. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD20.013MRQ28.508-8.495
MRQ28.508TTM2,160.789-2,132.282
TTM2,160.789YOY-34.654+2,195.443
TTM2,160.7895Y475.961+1,684.829
5Y475.96110Y417.818+58.143
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tus Pharmaceutical Group Co Ltd:

  • The EOD is -24.360. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -34.701. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 4.922. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-24.360MRQ-34.701+10.341
MRQ-34.701TTM4.922-39.623
TTM4.922YOY-1.535+6.457
TTM4.9225Y-51.422+56.345
5Y-51.42210Y-33.321-18.101
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tus Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Tus Pharmaceutical Group Co Ltd:

  • The EOD is 2.068. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.947. Based on the equity, the company is underpriced. +1
  • The TTM is 2.956. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.068MRQ2.947-0.878
MRQ2.947TTM2.956-0.009
TTM2.956YOY3.012-0.056
TTM2.9565Y3.561-0.605
5Y3.56110Y8.325-4.764
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tus Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0810.027+201%0.021+283%0.031+160%0.049+64%
Book Value Per Share--3.0412.980+2%2.917+4%2.780+9%2.117+44%
Current Ratio--2.1692.168+0%2.521-14%2.995-28%1.826+19%
Debt To Asset Ratio--0.3670.373-1%0.335+10%0.302+22%0.401-8%
Debt To Equity Ratio--0.5840.599-2%0.518+13%0.443+32%0.812-28%
Dividend Per Share--0.0050.004+13%0.001+885%0.001+260%0.002+144%
Eps--0.0790.026+198%0.019+315%0.030+161%0.023+247%
Free Cash Flow Per Share---0.065-0.054-17%0.037-273%-0.001-98%-0.001-98%
Free Cash Flow To Equity Per Share---0.065-0.075+16%0.154-142%0.017-482%0.017-484%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.872+15%
Intrinsic Value_10Y_max---0.806--------
Intrinsic Value_10Y_min---0.678--------
Intrinsic Value_1Y_max---0.031--------
Intrinsic Value_1Y_min---0.031--------
Intrinsic Value_3Y_max---0.131--------
Intrinsic Value_3Y_min---0.125--------
Intrinsic Value_5Y_max---0.277--------
Intrinsic Value_5Y_min---0.254--------
Market Cap1506272640.320-42%2145662552.3202109741862.270+2%2103755080.595+2%2337823150.068-8%2951422594.382-27%
Net Profit Margin--0.1450.052+178%0.008+1781%0.078+85%0.049+194%
Operating Margin---0.018-100%-0.0040%0.069-100%0.005-100%
Operating Ratio--1.4021.430-2%2.398-42%1.581-11%1.138+23%
Pb Ratio2.068-42%2.9472.9560%3.012-2%3.561-17%8.325-65%
Pe Ratio20.013-42%28.5082160.789-99%-34.654+222%475.961-94%417.818-93%
Price Per Share6.290-42%8.9608.810+2%8.785+2%9.762-8%12.324-27%
Price To Free Cash Flow Ratio-24.360+30%-34.7014.922-805%-1.535-96%-51.422+48%-33.321-4%
Price To Total Gains Ratio73.481-42%104.6721291.593-92%-271.721+360%346.541-70%516.844-80%
Quick Ratio--0.0870.634-86%0.962-91%0.804-89%0.692-87%
Return On Assets--0.0160.005+199%0.004+269%0.008+110%0.007+125%
Return On Equity--0.0260.009+196%0.007+298%0.011+137%0.015+72%
Total Gains Per Share--0.0860.031+174%0.022+297%0.032+164%0.051+67%
Usd Book Value--100637655.27498638881.340+2%96543549.776+4%91994173.746+9%70070517.073+44%
Usd Book Value Change Per Share--0.0110.004+201%0.003+283%0.004+160%0.007+64%
Usd Book Value Per Share--0.4200.412+2%0.403+4%0.384+9%0.293+44%
Usd Dividend Per Share--0.0010.001+13%0.000+885%0.000+260%0.000+144%
Usd Eps--0.0110.004+198%0.003+315%0.004+161%0.003+247%
Usd Free Cash Flow---2136333.074-1776958.256-17%1236518.154-273%-37172.419-98%-22407.120-99%
Usd Free Cash Flow Per Share---0.009-0.007-17%0.005-273%0.000-98%0.000-98%
Usd Free Cash Flow To Equity Per Share---0.009-0.010+16%0.021-142%0.002-482%0.002-484%
Usd Market Cap208166878.892-42%296530564.731291566325.366+2%290738952.138+2%323087159.339-8%407886602.544-27%
Usd Price Per Share0.869-42%1.2381.218+2%1.214+2%1.349-8%1.703-27%
Usd Profit--2600458.125872276.206+198%626939.295+315%995011.972+161%749869.730+247%
Usd Revenue--17968497.62913980585.229+29%12110746.205+48%11374379.701+58%10156331.550+77%
Usd Total Gains Per Share--0.0120.004+174%0.003+297%0.004+164%0.007+67%
 EOD+3 -5MRQTTM+28 -7YOY+23 -115Y+20 -1510Y+24 -12

3.2. Fundamental Score

Let's check the fundamental score of Tus Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.013
Price to Book Ratio (EOD)Between0-12.068
Net Profit Margin (MRQ)Greater than00.145
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.087
Current Ratio (MRQ)Greater than12.169
Debt to Asset Ratio (MRQ)Less than10.367
Debt to Equity Ratio (MRQ)Less than10.584
Return on Equity (MRQ)Greater than0.150.026
Return on Assets (MRQ)Greater than0.050.016
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Tus Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.226
Ma 20Greater thanMa 507.223
Ma 50Greater thanMa 1006.896
Ma 100Greater thanMa 2008.018
OpenGreater thanClose6.450
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Selling General Administrative  20,16921,91742,086-32,7629,32460,58369,908-89,082-19,174



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,151,121
Total Liabilities422,918
Total Stockholder Equity723,718
 As reported
Total Liabilities 422,918
Total Stockholder Equity+ 723,718
Total Assets = 1,151,121

Assets

Total Assets1,151,121
Total Current Assets539,552
Long-term Assets611,569
Total Current Assets
Cash And Cash Equivalents 189,770
Net Receivables 21,548
Inventory 130,087
Other Current Assets 2,251
Total Current Assets  (as reported)539,552
Total Current Assets  (calculated)343,655
+/- 195,896
Long-term Assets
Property Plant Equipment 293,811
Goodwill 131,645
Intangible Assets 132,327
Long-term Assets Other 1,759
Long-term Assets  (as reported)611,569
Long-term Assets  (calculated)559,541
+/- 52,028

Liabilities & Shareholders' Equity

Total Current Liabilities248,770
Long-term Liabilities174,148
Total Stockholder Equity723,718
Total Current Liabilities
Accounts payable 83,553
Other Current Liabilities 6,033
Total Current Liabilities  (as reported)248,770
Total Current Liabilities  (calculated)89,586
+/- 159,184
Long-term Liabilities
Long term Debt 80,000
Capital Lease Obligations Min Short Term Debt3,070
Long-term Liabilities Other 517
Long-term Liabilities  (as reported)174,148
Long-term Liabilities  (calculated)83,587
+/- 90,560
Total Stockholder Equity
Total Stockholder Equity (as reported)723,718
Total Stockholder Equity (calculated)0
+/- 723,718
Other
Capital Stock239,471
Common Stock Shares Outstanding 239,471
Net Invested Capital 803,718
Net Working Capital 290,782
Property Plant and Equipment Gross 293,811



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
618,239
636,255
734,738
695,050
700,411
692,256
690,144
724,861
709,812
710,740
697,735
685,160
667,238
669,039
661,717
676,627
652,903
646,623
633,643
664,584
648,268
640,406
661,958
545,359
552,514
563,048
537,518
548,583
528,446
566,329
570,638
571,308
582,908
569,193
576,461
516,335
494,562
500,669
530,560
568,726
568,040
599,592
594,773
602,454
634,271
692,388
649,517
704,018
696,193
657,301
649,844
552,562
519,377
523,933
559,406
586,821
536,277
575,753
619,934
587,435
599,683
611,473
592,369
630,679
554,823
847,260
815,603
873,736
845,280
836,684
821,376
816,599
811,387
819,134
830,574
846,744
841,742
848,739
859,540
892,158
920,837
911,756
920,937
967,826
962,748
963,489
1,141,076
1,166,754
1,160,865
1,124,199
1,117,444
1,151,121
1,151,1211,117,4441,124,1991,160,8651,166,7541,141,076963,489962,748967,826920,937911,756920,837892,158859,540848,739841,742846,744830,574819,134811,387816,599821,376836,684845,280873,736815,603847,260554,823630,679592,369611,473599,683587,435619,934575,753536,277586,821559,406523,933519,377552,562649,844657,301696,193704,018649,517692,388634,271602,454594,773599,592568,040568,726530,560500,669494,562516,335576,461569,193582,908571,308570,638566,329528,446548,583537,518563,048552,514545,359661,958640,406648,268664,584633,643646,623652,903676,627661,717669,039667,238685,160697,735710,740709,812724,861690,144692,256700,411695,050734,738636,255618,239
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
479,533
464,416
486,968
484,670
479,025
483,067
491,486
483,289
484,922
494,919
508,616
528,300
519,472
527,961
553,885
552,516
554,256
509,525
529,110
525,509
494,285
483,390
539,552
539,552483,390494,285525,509529,110509,525554,256552,516553,885527,961519,472528,300508,616494,919484,922483,289491,486483,067479,025484,670486,968464,416479,533000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
221,510
221,979
321,355
305,673
299,720
302,233
314,337
302,350
346,403
295,477
342,953
297,403
226,438
181,190
250,681
119,943
316,437
175,947
235,421
184,927
200,371
156,223
189,770
189,770156,223200,371184,927235,421175,947316,437119,943250,681181,190226,438297,403342,953295,477346,403302,350314,337302,233299,720305,673321,355221,979221,510000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100,000
0
0
0
0
0
0
0
0
60,000
0
40,680
130,630
166,650
75,146
164,536
52,000
42,000
25,109
20,098
0
55,000
0
055,000020,09825,10942,00052,000164,53675,146166,650130,63040,680060,00000000000100,000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
178,447
213,592
279,750
225,566
221,148
216,194
233,373
194,450
201,521
256,633
252,521
220,438
211,112
209,815
217,101
238,914
226,357
223,510
219,979
225,601
217,637
264,365
300,985
296,563
288,918
219,908
170,073
204,473
193,315
221,397
215,419
159,837
173,339
168,332
167,376
119,317
98,719
67,586
116,485
129,621
102,545
120,241
111,813
105,060
124,002
100,565
146,064
151,348
132,521
134,166
142,842
107,362
97,221
126,637
147,382
143,398
114,172
140,207
142,501
112,323
141,730
112,003
102,296
94,060
90,729
107,838
80,784
139,610
145,692
73,988
66,827
65,646
2,904
3,128
3,954
125,523
124,232
79,889
81,341
113,043
137,590
104,588
100,954
130,817
150,263
76,655
145,829
147,267
180,525
163,430
146,874
21,548
21,548146,874163,430180,525147,267145,82976,655150,263130,817100,954104,588137,590113,04381,34179,889124,232125,5233,9543,1282,90465,64666,82773,988145,692139,61080,784107,83890,72994,060102,296112,003141,730112,323142,501140,207114,172143,398147,382126,63797,221107,362142,842134,166132,521151,348146,064100,565124,002105,060111,813120,241102,545129,621116,48567,58698,719119,317167,376168,332173,339159,837215,419221,397193,315204,473170,073219,908288,918296,563300,985264,365217,637225,601219,979223,510226,357238,914217,101209,815211,112220,438252,521256,633201,521194,450233,373216,194221,148225,566279,750213,592178,447
       Other Current Assets 
1,929
9,195
6,859
18,856
6,170
10,877
8,211
13,305
8,115
9,630
4,747
9,855
5,885
5,886
4,381
10,321
6,533
8,507
9,585
9,892
4,842
5,946
5,051
6,545
2,132
9,775
4,901
12,763
946
5,242
8,036
7,084
8,028
7,397
8,690
7,615
8,798
12,931
8,884
10,558
12,495
12,007
13,952
9,183
7,954
10,058
9,527
10,204
12,341
11,793
8,358
42,878
34,913
37,512
26,909
1,634
1,704
1,838
3,750
1,210
10,257
1,595
816
949
707
1,688
194,918
1,762
196,470
791
101,358
29,159
28,802
27,746
28,168
411
1,156
667
1,333
1,231
2,000
1,985
1,430
10,648
33,400
27,125
31,065
3,056
6,594
2,336
2,831
2,251
2,2512,8312,3366,5943,05631,06527,12533,40010,6481,4301,9852,0001,2311,3336671,15641128,16827,74628,80229,159101,358791196,4701,762194,9181,6887079498161,59510,2571,2103,7501,8381,7041,63426,90937,51234,91342,8788,35811,79312,34110,2049,52710,0587,9549,18313,95212,00712,49510,5588,88412,9318,7987,6158,6907,3978,0287,0848,0365,24294612,7634,9019,7752,1326,5455,0515,9464,8429,8929,5858,5076,53310,3214,3815,8865,8859,8554,7479,6308,11513,3058,21110,8776,17018,8566,8599,1951,929
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
326,717
340,109
347,507
355,258
358,453
363,817
364,622
383,542
392,538
392,285
392,976
413,941
410,232
409,233
631,551
637,644
635,356
629,914
634,054
611,569
611,569634,054629,914635,356637,644631,551409,233410,232413,941392,976392,285392,538383,542364,622363,817358,453355,258347,507340,109326,717000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
197,542
212,831
259,920
248,819
249,282
253,953
253,658
254,414
254,755
222,898
221,715
219,442
215,852
215,448
213,782
212,293
210,182
250,194
207,873
258,309
211,814
240,606
194,849
171,352
127,580
210,586
128,153
211,792
126,174
207,709
124,713
270,763
128,379
268,083
129,416
273,887
135,295
273,507
141,581
289,776
161,464
299,087
165,999
311,144
178,734
308,954
182,544
309,567
177,169
304,857
172,244
267,805
121,168
119,729
127,411
161,956
165,756
169,834
188,972
151,576
152,405
156,039
156,010
157,798
166,507
169,154
174,578
164,784
169,854
172,692
172,435
171,348
169,368
182,247
190,914
200,963
205,602
205,753
207,843
224,732
234,974
235,722
237,655
240,889
238,802
238,219
283,057
289,745
290,815
290,158
294,745
293,811
293,811294,745290,158290,815289,745283,057238,219238,802240,889237,655235,722234,974224,732207,843205,753205,602200,963190,914182,247169,368171,348172,435172,692169,854164,784174,578169,154166,507157,798156,010156,039152,405151,576188,972169,834165,756161,956127,411119,729121,168267,805172,244304,857177,169309,567182,544308,954178,734311,144165,999299,087161,464289,776141,581273,507135,295273,887129,416268,083128,379270,763124,713207,709126,174211,792128,153210,586127,580171,352194,849240,606211,814258,309207,873250,194210,182212,293213,782215,448215,852219,442221,715222,898254,755254,414253,658253,953249,282248,819259,920212,831197,542
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,249
7,249
7,249
7,249
7,249
7,249
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
136,524
137,144
137,144
137,144
137,144
131,645
131,645137,144137,144137,144137,144136,52400000000000000000007,2497,2497,2497,2497,2497,2490000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
129
0
0
0
1,211
1,211
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001,2111,211000129000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
49,935
53,792
39,988
39,572
40,183
41,396
41,964
92,039
90,253
81,386
78,845
76,102
73,401
71,496
68,745
66,716
64,796
52,728
59,150
51,474
54,114
51,474
43,321
51,600
14,373
3,906
86,347
1,377
84,579
2,078
84,598
837
141,013
653
139,694
606
138,481
642
137,220
662
136,003
640
134,743
641
133,507
615
132,244
589
130,981
563
129,718
537
147,450
146,719
145,970
156,113
155,333
155,543
154,740
191,219
190,232
196,589
195,639
178,699
177,810
176,921
176,032
167,871
166,984
166,097
165,456
137,606
136,880
-54
135,428
134,702
133,976
139,704
138,932
138,161
137,390
136,618
135,847
133,694
132,945
132,076
159,705
157,439
155,886
154,623
153,063
132,327
132,327153,063154,623155,886157,439159,705132,076132,945133,694135,847136,618137,390138,161138,932139,704133,976134,702135,428-54136,880137,606165,456166,097166,984167,871176,032176,921177,810178,699195,639196,589190,232191,219154,740155,543155,333156,113145,970146,719147,450537129,718563130,981589132,244615133,507641134,743640136,003662137,220642138,481606139,694653141,01383784,5982,07884,5791,37786,3473,90614,37351,60043,32151,47454,11451,47459,15052,72864,79666,71668,74571,49673,40176,10278,84581,38690,25392,03941,96441,39640,18339,57239,98853,79249,935
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
326,717
340,109
347,507
355,258
358,453
0
207,843
341
341
341
341
278
0
1,002
0
1,854
1,170
1,150
1,150
1,759
1,7591,1501,1501,1701,85401,0020278341341341341207,8430358,453355,258347,507340,109326,717000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
257,284
256,237
357,223
416,400
423,533
420,453
417,657
443,956
432,666
424,785
415,663
425,999
412,032
416,289
411,112
409,059
384,780
378,579
366,691
396,045
381,761
374,571
369,454
274,098
266,218
267,335
238,968
241,367
222,183
246,025
246,974
248,531
258,173
249,368
257,986
285,112
265,777
268,294
272,281
289,846
269,695
293,536
266,023
251,621
266,455
291,462
263,690
225,436
201,819
190,661
214,786
283,051
246,787
252,234
288,126
402,714
341,219
379,243
404,491
381,640
380,401
386,252
367,950
366,723
279,526
290,630
259,620
290,405
256,492
249,898
249,253
236,880
220,880
224,041
233,523
224,583
210,700
212,743
218,053
247,274
255,492
237,673
236,988
285,504
266,476
268,086
440,932
464,260
451,762
415,432
408,556
422,918
422,918408,556415,432451,762464,260440,932268,086266,476285,504236,988237,673255,492247,274218,053212,743210,700224,583233,523224,041220,880236,880249,253249,898256,492290,405259,620290,630279,526366,723367,950386,252380,401381,640404,491379,243341,219402,714288,126252,234246,787283,051214,786190,661201,819225,436263,690291,462266,455251,621266,023293,536269,695289,846272,281268,294265,777285,112257,986249,368258,173248,531246,974246,025222,183241,367238,968267,335266,218274,098369,454374,571381,761396,045366,691378,579384,780409,059411,112416,289412,032425,999415,663424,785432,666443,956417,657420,453423,533416,400357,223256,237257,284
   > Total Current Liabilities 
246,286
220,687
281,932
392,059
399,193
396,112
393,315
421,815
410,525
402,644
393,521
406,058
392,091
396,348
391,470
393,518
369,239
363,038
351,149
380,503
366,220
371,300
366,183
274,098
266,218
267,335
238,968
241,142
221,958
245,770
246,119
234,460
244,042
235,223
243,850
274,915
255,550
258,165
262,110
289,685
269,516
293,379
265,882
251,521
266,344
291,353
263,585
218,340
194,709
183,568
207,652
275,940
236,354
241,765
277,593
318,174
256,388
294,277
284,465
264,838
263,667
268,186
249,953
254,594
169,984
161,173
129,248
164,642
130,872
120,585
120,088
141,023
125,229
128,596
139,301
153,915
140,188
140,577
145,694
161,016
163,409
145,129
144,108
186,984
167,431
167,951
332,006
271,418
258,131
221,851
215,741
248,770
248,770215,741221,851258,131271,418332,006167,951167,431186,984144,108145,129163,409161,016145,694140,577140,188153,915139,301128,596125,229141,023120,088120,585130,872164,642129,248161,173169,984254,594249,953268,186263,667264,838284,465294,277256,388318,174277,593241,765236,354275,940207,652183,568194,709218,340263,585291,353266,344251,521265,882293,379269,516289,685262,110258,165255,550274,915243,850235,223244,042234,460246,119245,770221,958241,142238,968267,335266,218274,098366,183371,300366,220380,503351,149363,038369,239393,518391,470396,348392,091406,058393,521402,644410,525421,815393,315396,112399,193392,059281,932220,687246,286
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
10,000
10,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000010,00010,00010,000000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
10,000
10,000
0
0
5,000
5,000
5,000
5,000
0
0
0
0
0
18,000
25,825
35,000
10,000
5,000
0
05,00010,00035,00025,82518,000000005,0005,0005,0005,0000010,00010,00010,000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
70,111
66,047
86,369
92,470
87,331
96,679
104,248
110,857
116,104
93,344
86,061
87,557
79,840
75,591
72,003
84,482
71,020
70,779
63,775
70,918
65,848
75,157
67,176
54,064
52,764
53,380
49,618
46,982
52,822
54,464
53,687
71,980
78,442
67,472
64,773
67,490
67,877
66,217
62,881
78,382
72,947
74,928
74,615
73,270
74,408
77,725
79,997
83,331
82,730
81,569
83,381
86,326
67,947
66,394
58,780
46,700
46,384
39,618
41,814
41,646
40,592
40,022
45,703
41,666
40,317
50,226
52,064
44,336
47,548
49,528
27,908
26,557
31,039
30,636
35,933
34,883
38,453
36,178
36,854
38,625
45,958
42,039
43,729
41,667
43,105
43,513
48,834
64,012
73,015
63,827
70,619
83,553
83,55370,61963,82773,01564,01248,83443,51343,10541,66743,72942,03945,95838,62536,85436,17838,45334,88335,93330,63631,03926,55727,90849,52847,54844,33652,06450,22640,31741,66645,70340,02240,59241,64641,81439,61846,38446,70058,78066,39467,94786,32683,38181,56982,73083,33179,99777,72574,40873,27074,61574,92872,94778,38262,88166,21767,87767,49064,77367,47278,44271,98053,68754,46452,82246,98249,61853,38052,76454,06467,17675,15765,84870,91863,77570,77971,02084,48272,00375,59179,84087,55786,06193,344116,104110,857104,24896,67987,33192,47086,36966,04770,111
       Other Current Liabilities 
93,620
81,025
59,666
71,419
97,842
66,381
66,023
80,315
77,802
65,797
54,057
66,248
70,018
74,664
73,543
72,264
62,147
57,759
57,757
83,727
77,186
76,180
79,001
66,537
61,007
80,528
55,500
70,310
56,136
64,306
65,432
66,480
69,600
72,751
79,077
102,282
111,423
122,080
136,361
143,563
144,989
141,511
138,687
115,671
114,056
156,048
182,588
135,009
111,979
101,999
106,101
189,614
167,907
174,871
168,813
193,954
185,004
160,409
150,001
159,242
172,925
155,764
129,700
134,627
92,767
97,448
73,185
120,307
83,323
65,243
68,358
73,809
72,808
72,628
81,379
88,420
89,362
84,389
89,734
84,099
99,490
86,801
84,989
97,671
103,567
94,679
242,812
117,990
128,218
119,497
116,040
6,033
6,033116,040119,497128,218117,990242,81294,679103,56797,67184,98986,80199,49084,09989,73484,38989,36288,42081,37972,62872,80873,80968,35865,24383,323120,30773,18597,44892,767134,627129,700155,764172,925159,242150,001160,409185,004193,954168,813174,871167,907189,614106,101101,999111,979135,009182,588156,048114,056115,671138,687141,511144,989143,563136,361122,080111,423102,28279,07772,75169,60066,48065,43264,30656,13670,31055,50080,52861,00766,53779,00176,18077,18683,72757,75757,75962,14772,26473,54374,66470,01866,24854,05765,79777,80280,31566,02366,38197,84271,41959,66681,02593,620
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95,651
95,445
94,222
70,668
70,512
72,166
72,360
86,258
92,083
92,544
92,880
98,521
99,044
100,135
108,926
192,842
193,631
193,581
192,815
174,148
174,148192,815193,581193,631192,842108,926100,13599,04498,52192,88092,54492,08386,25872,36072,16670,51270,66894,22295,44595,651000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
225
225
255
855
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,000
7,000
6,999
7,000
7,000
10,289
10,289
10,289
84,312
84,371
84,371
119,852
116,802
116,734
118,065
117,997
112,130
109,542
109,457
110,372
105,763
105,620
109,313
109,165
75,857
75,651
75,445
74,222
70,668
70,512
72,166
72,360
86,258
87,741
88,314
88,691
92,935
93,386
93,709
101,938
97,666
98,188
98,192
97,700
0
097,70098,19298,18897,666101,93893,70993,38692,93588,69188,31487,74186,25872,36072,16670,51270,66874,22275,44575,65175,857109,165109,313105,620105,763110,372109,457109,542112,130117,997118,065116,734116,802119,85284,37184,37184,31210,28910,28910,2897,0007,0006,9997,0007,0000000000000000000855255225225000000011000000010001000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,011
1,872
3,746
3,783
3,501
3,224
2,947
2,670
2,393
2,116
1,839
1,699
1,800
1,664
1,816
1,576
1,387
3,239
2,932
2,781
2,459
2,195
0
02,1952,4592,7812,9323,2391,3871,5761,8161,6641,8001,6991,8392,1162,3932,6702,9473,2243,5013,7833,7461,8721,011000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
360,425
375,294
370,324
279,942
278,265
273,787
274,675
283,834
280,332
284,038
280,233
258,465
254,663
252,345
250,324
267,508
268,173
268,226
267,191
269,155
265,191
264,977
272,148
271,296
286,320
295,713
298,549
307,216
306,262
320,304
323,664
322,778
324,736
319,825
318,475
231,223
228,785
232,375
258,280
278,881
298,345
306,056
328,750
350,833
367,816
400,926
385,827
478,581
494,373
466,640
435,058
269,511
272,590
271,700
271,280
184,106
195,058
196,510
215,442
205,794
219,283
217,743
218,133
260,970
271,677
554,087
554,722
583,331
588,789
586,786
572,123
579,719
590,507
595,093
597,052
622,161
631,042
635,996
641,487
644,883
665,346
674,083
683,949
680,322
692,824
691,876
696,021
698,468
705,053
704,851
704,899
723,718
723,718704,899704,851705,053698,468696,021691,876692,824680,322683,949674,083665,346644,883641,487635,996631,042622,161597,052595,093590,507579,719572,123586,786588,789583,331554,722554,087271,677260,970218,133217,743219,283205,794215,442196,510195,058184,106271,280271,700272,590269,511435,058466,640494,373478,581385,827400,926367,816350,833328,750306,056298,345278,881258,280232,375228,785231,223318,475319,825324,736322,778323,664320,304306,262307,216298,549295,713286,320271,296272,148264,977265,191269,155267,191268,226268,173267,508250,324252,345254,663258,465280,233284,038280,332283,834274,675273,787278,265279,942370,324375,294360,425
   Common Stock
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
203,028
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
223,331
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
239,471
0
0239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471239,471223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331223,331203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028203,028
   Retained Earnings 
15,234
27,704
23,479
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,638
27,589
52,574
17,184
56,632
72,380
44,696
12,995
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-92,181
-106,845
-133,816
-168,927
-164,341
-162,382
-91,374
-82,493
-77,539
-72,048
-68,652
-48,189
-39,452
-29,586
-33,213
-20,711
-21,659
-17,514
-15,067
-8,482
-8,685
-8,637
-35,716
-35,716-8,637-8,685-8,482-15,067-17,514-21,659-20,711-33,213-29,586-39,452-48,189-68,652-72,048-77,539-82,493-91,374-162,382-164,341-168,927-133,816-106,845-92,18100000000000000000012,99544,69672,38056,63217,18452,57427,58910,638000000000000000000000000000000000000000023,47927,70415,234
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue404,648
Cost of Revenue-192,529
Gross Profit212,119212,119
 
Operating Income (+$)
Gross Profit212,119
Operating Expense-384,158
Operating Income20,490-172,039
 
Operating Expense (+$)
Research Development12,820
Selling General Administrative102,144
Selling And Marketing Expenses0
Operating Expense384,158114,964
 
Net Interest Income (+$)
Interest Income2,240
Interest Expense-4,462
Other Finance Cost-117
Net Interest Income-2,106
 
Pretax Income (+$)
Operating Income20,490
Net Interest Income-2,106
Other Non-Operating Income Expenses0
Income Before Tax (EBT)29,67920,490
EBIT - interestExpense = -4,462
25,247
29,709
Interest Expense4,462
Earnings Before Interest and Taxes (EBIT)034,142
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax29,679
Tax Provision-4,789
Net Income From Continuing Ops24,89024,890
Net Income25,247
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,106
 

Technical Analysis of Tus Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tus Pharmaceutical Group Co Ltd. The general trend of Tus Pharmaceutical Group Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tus Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tus Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.07 < 8.27 < 8.63.

The bearish price targets are: 4.8.

Tweet this
Tus Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tus Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tus Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tus Pharmaceutical Group Co Ltd. The current macd is -0.18093693.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tus Pharmaceutical Group Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tus Pharmaceutical Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tus Pharmaceutical Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tus Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTus Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tus Pharmaceutical Group Co Ltd. The current adx is 19.23.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tus Pharmaceutical Group Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Tus Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tus Pharmaceutical Group Co Ltd. The current sar is 7.85884577.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tus Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tus Pharmaceutical Group Co Ltd. The current rsi is 39.23. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Tus Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartTus Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tus Pharmaceutical Group Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tus Pharmaceutical Group Co Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Tus Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartTus Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tus Pharmaceutical Group Co Ltd. The current cci is -161.26683655.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Tus Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartTus Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tus Pharmaceutical Group Co Ltd. The current cmo is -27.55576225.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tus Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartTus Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tus Pharmaceutical Group Co Ltd. The current willr is -80.16194332.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Tus Pharmaceutical Group Co Ltd Daily Williams %R ChartTus Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tus Pharmaceutical Group Co Ltd.

Tus Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tus Pharmaceutical Group Co Ltd. The current atr is 0.41819662.

Tus Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartTus Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tus Pharmaceutical Group Co Ltd. The current obv is 120,539,911.

Tus Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartTus Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tus Pharmaceutical Group Co Ltd. The current mfi is 58.91.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Tus Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartTus Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tus Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Tus Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tus Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.226
Ma 20Greater thanMa 507.223
Ma 50Greater thanMa 1006.896
Ma 100Greater thanMa 2008.018
OpenGreater thanClose6.450
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tus Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Tus Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tus Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tus Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Tus Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tus Pharmaceutical Group Co Ltd.

Receive notifications about Tus Pharmaceutical Group Co Ltd in your mailbox!